dihydroxyphenylalanine has been researched along with Osteoporosis in 4 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Osteoporosis: Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Drugs are normally prescribed to treat osteoporosis, especially after surgical treatment of osteoporotic fractures." | 1.91 | Bio-orthogonal engineered peptide: A multi-functional strategy for the gene therapy of osteoporotic bone loss. ( Bai, J; Chu, PK; Gao, A; Ge, G; Geng, D; Liu, X; Wang, G; Wang, H; Wang, Q; Wang, W; Wu, Z; Yu, L, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, W | 1 |
| Wang, Q | 1 |
| Yu, L | 1 |
| Ge, G | 1 |
| Liu, X | 1 |
| Gao, A | 1 |
| Wang, G | 1 |
| Wu, Z | 1 |
| Bai, J | 1 |
| Wang, H | 1 |
| Chu, PK | 1 |
| Geng, D | 1 |
| Matsumoto, M | 1 |
| Müller-Plettenberg, D | 1 |
| Greenberg, J | 1 |
1 review available for dihydroxyphenylalanine and Osteoporosis
| Article | Year |
|---|---|
[Gradual regulation of osteoclastogenesis mediated by p38 MAP kinase].
Topics: Animals; Arthritis, Rheumatoid; Cell Differentiation; Dihydroxyphenylalanine; Drug Design; Enzyme In | 2007 |
3 other studies available for dihydroxyphenylalanine and Osteoporosis
| Article | Year |
|---|---|
Bio-orthogonal engineered peptide: A multi-functional strategy for the gene therapy of osteoporotic bone loss.
Topics: Aged; Dihydroxyphenylalanine; Humans; Osteoporosis; Osteoporotic Fractures; Peptides; Reactive Oxyge | 2023 |
[Notes from the Annual Congress 1972 of the German Society of Gerontology].
Topics: Aged; Aging; Arteriosclerosis; Congresses as Topic; Connective Tissue; Depression; Dihydroxyphenylal | 1973 |
L-dopa treatment too successful.
Topics: Aged; Dihydroxyphenylalanine; Femoral Neck Fractures; Humans; Male; Middle Aged; Osteoporosis; Parki | 1969 |